Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127098432 | 12709843 | 2 | F | 20160912 | 20160902 | 20160916 | EXP | PHHY2016MX120314 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160916 | CN | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127098432 | 12709843 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 4 DF, QD (SINCE APPROXIMATELY 25 YEARS AGO) | 71993 | 20234 | 4 | DF | EXTENDED RELEASE TABLET | QD | |||||
| 127098432 | 12709843 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | 20234 | EXTENDED RELEASE TABLET | |||||||||||
| 127098432 | 12709843 | 3 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 1 DF (300/750 MG), QD, 6 MONTHS AGO | 0 | 1 | DF | EXTENDED RELEASE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127098432 | 12709843 | 1 | Seizure |
| 127098432 | 12709843 | 2 | Anxiety disorder |
| 127098432 | 12709843 | 3 | Psychomotor retardation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127098432 | 12709843 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |